SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-253882
Filing Date
2023-10-11
Accepted
2023-10-11 08:13:29
Documents
18
Period of Report
2023-10-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d547808d8k.htm   iXBRL 8-K 50071
2 EX-3.1 d547808dex31.htm EX-3.1 21592
3 EX-4.1 d547808dex41.htm EX-4.1 304635
4 EX-99.1 d547808dex991.htm EX-99.1 33102
5 EX-99.2 d547808dex992.htm EX-99.2 10662
9 GRAPHIC g547808dsp16.jpg GRAPHIC 32000
10 GRAPHIC g547808g1009212232581.jpg GRAPHIC 8253
  Complete submission text file 0001193125-23-253882.txt   703792

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA tpst-20231010.xsd EX-101.SCH 2857
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE tpst-20231010_lab.xml EX-101.LAB 18740
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tpst-20231010_pre.xml EX-101.PRE 11712
12 EXTRACTED XBRL INSTANCE DOCUMENT d547808d8k_htm.xml XML 3568
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 415-798-8589
Tempest Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35890 | Film No.: 231319454
SIC: 2834 Pharmaceutical Preparations